معرفی
Per Eriksson is a Professor in the Department of Medicine, Solna at Karolinska Institutet. His research focuses on molecular and epidemiological studies of ascending aortic aneurysms, particularly within the Research Group of Hanna Björck. He holds a Docent title from Karolinska Institutet (1999). His work bridges cardiology, molecular biology, and cell biology, investigating mechanisms underlying aortic aneurysm development and cardiovascular disease progression.
Research Interests: Dr. Eriksson’s research emphasizes molecular mechanisms of aortic aneurysm formation, cardiovascular risk prediction using carotid imaging (e.g., IMPROVE Study), and the role of lipoproteins, immune cells, and endothelial dysfunction in vascular pathology. He also explores genetic and proteomic factors in metabolic liver diseases and atherosclerosis.
Recent Article Themes: His 15 most recent articles (2023–2025) highlight advanced techniques like machine learning for subclinical atherosclerosis endotyping, proteomic profiling of cardiovascular risk factors, and mechanistic studies on Kupffer cell roles in hepatic lipid metabolism. Key topics include statin effects on hepatic genes, endothelial regulatory pathways in elite athletes, and predictive models for aortic valve-related dilatation.
Grants: His funding includes Swedish Research Council grants for thoracic aortic aneurysm research (2021–2023), the MIBAVA Leducq Transatlantic Network (2012), and Swedish Heart-Lung Foundation support for aortic valve disease studies. Industrialist Fredrik Lundberg’s donations have also supported cardiovascular research at KI.
Labs/Teams: A key member of the Molecular and Epidemiological Studies group under Prof. Hanna Björck, focusing on translational research connecting genetic, proteomic, and clinical data to vascular disease mechanisms.
